AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Australian Clinical Labs Ltd

2.200

+0.0301.38%

Volume:63.53K

Turnover:138.84K

Market Cap:422.89M

PE:15.61

High:2.200

Open:2.160

Low:2.160

Close:2.170

52wk High:3.494

52wk Low:2.080

Shares:192.22M

Float Shares:187.68M

Volume Ratio:0.71

T/O Rate:0.03%

Dividend:0.13

Dividend Rate:5.68%

EPS(TTM):0.141

EPS(LYR):0.171

ROE:16.68%

ROA:7.48%

PB:2.81

PE(LYR):12.90

Loading ...

Overview Company News Filings

A Look At Australian Clinical Labs (ASX:ACL) Valuation After Softer Half Year Earnings And Interim Dividend

Simply Wall St.

Australian Clinical Labs Inflicts Pain With Profit Downgrade, CEO Exit -- Market Talk

BRIEF-Australian Clinical Labs Group CEO Melinda Mcgrath Confirms Will Not Be Renewing Contract

Australian Clinical Labs Ltd - Group CEO Melinda McGrath Confirmed Will Not Be Renewing Contract Following Conclusion on 30 August

THOMSON REUTERS

BRIEF-Australian Clinical Labs Sees FY26 Revenue A$735M - A$745M

3 ASX Penny Stocks With Market Caps Under A$600M To Consider

Simply Wall St.

The 2025 AGM Season Shows Shareholder Scrutiny, Focus on Board Accountability, Says Jarden

MT Newswires Live

Optiscan Imaging, Australian Clinical Labs to Collaborate on Head, Neck Cancer Surgery Imaging Study

MT Newswires Live

We’re not in Kansas anymore

MOEA Takes Home 7 Awards at R&D100

Optiscan Imaging Enters Strategic Collaboration With Australian Clinical Labs

Australian Clinical Labs Ltd-Update - Notification of Buy-Back - Acl

THOMSON REUTERS

BUZZ-Australian Clinical Labs hits seven-week high on share buyback

Australian Clinical Labs Ltd - on Market Share Buy Back of up to 19.5 Mln Acl Shares

THOMSON REUTERS

Australian Clinical Labs Ltd-Resignation of DR Leanne Rowe Am

THOMSON REUTERS

BRIEF-Australian Clinical Labs Says Court Approves Agreement With Australian Information Commissioner

Australian Clinical Labs Ltd - Co Will Pay Aggregate Civil Penalties of a$5.8 Mln

THOMSON REUTERS

BUZZ-Australian Clinical Labs falls on $3.8 million penalty

Australian Clinical Labs Ltd - Proposes a$5.8 Mln Penalty

THOMSON REUTERS

Australian Clinical Labs Ltd - Acl and Australian Information Commissioner Reach Agreement on Privacy Act Proceeding

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACL.AU\",,,,,undefined,":{"symbol":"ACL.AU","market":"AU","secType":"STK","nameCN":"Australian Clinical Labs Ltd","latestPrice":2.2,"timestamp":1771975555134,"preClose":2.17,"halted":0,"volume":63533,"delay":0,"changeRate":0.013824884792626843,"nameEN":"Australian Clinical Labs Ltd","floatShares":187681218,"shares":192220870,"eps":0.140961,"marketStatus":"Trading","change":0.03,"latestTime":"02-25 10:25:58 AEDT","open":2.16,"high":2.2,"low":2.16,"amount":138838,"amplitude":0.018433,"askPrice":2.21,"askSize":3819,"bidPrice":2.19,"bidSize":6743,"shortable":3,"etf":0,"ttmEps":0.140961,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771995600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.17,"dividendRate":0.056818,"openAndCloseTimeList":[[1771974000000,1771995600000]],"volumeRatio":0.710415,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACL.AU\",,,,,undefined,":{"symbol":"ACL.AU","floatShares":187681218,"roa":"7.48%","roe":"16.68%","lyrEps":0.1705,"volumeRatio":0.710415,"shares":192220870,"dividePrice":0.125,"high":2.2,"amplitude":0.018433,"preClose":2.17,"low":2.16,"week52Low":2.08,"pbRate":"2.81","psRate":"0.57","week52High":3.494,"institutionHeld":0,"latestPrice":2.2,"committee":0.276842,"eps":0.140961,"divideRate":0.056818,"volume":63533,"delay":0,"ttmEps":0.140961,"open":2.16,"prevYearClose":2.75,"prevWeekClose":2.26,"prevMonthClose":2.73,"prevQuarterClose":2.75,"fiveDayClose":2.15,"twentyDayClose":2.67,"sixtyDayClose":2.86,"dividendPayoutRate":0.7289819912288886,"dividendGrowthYears":1,"dividendGrowthRate":0.24999999999999994,"fiveYearAvgDividendRate":0.07489242701713679},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-12","symbol":"ACL.AU","amount":0.0375,"announcedDate":"2026-02-16","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-13","defaultRemindTime":1773270000000,"name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-13","currency":"AUD","dateTimestamp":1773234000000,"payDate":"2026-03-31"},{"date":"2026-02-16","symbol":"ACL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771196400000,"name":null,"time":"","dateTimestamp":1771160400000,"actualEps":null},{"date":"2025-09-01","symbol":"ACL.AU","amount":0.09,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-02","defaultRemindTime":1756684800000,"name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-02","currency":"AUD","dateTimestamp":1756648800000,"payDate":"2025-09-23"},{"date":"2025-08-26","symbol":"ACL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-03-27","symbol":"ACL.AU","amount":0.035,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-28","name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-16","payableDate":"2025-03-28","currency":"AUD","dateTimestamp":1742994000000,"payDate":"2025-04-16"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2022-08-23","recordDate":"2022-08-24","paymentDate":"2022-09-15","value":0.41,"currency":"AUD"},{"executeDate":"2023-03-27","recordDate":"2023-03-28","paymentDate":"2023-04-26","value":0.07,"currency":"AUD"},{"executeDate":"2023-09-14","recordDate":"2023-09-15","paymentDate":"2023-10-03","value":0.07,"currency":"AUD"},{"executeDate":"2024-03-28","recordDate":"2024-04-02","paymentDate":"2024-04-26","value":0.03,"currency":"AUD"},{"executeDate":"2024-09-04","recordDate":"2024-09-05","paymentDate":"2024-09-27","value":0.09,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612123444","title":"A Look At Australian Clinical Labs (ASX:ACL) Valuation After Softer Half Year Earnings And Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2612123444","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612123444?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:16","pubTimestamp":1771416992,"startTime":"0","endTime":"0","summary":"Australian Clinical Labs (ASX:ACL) is in focus after reporting half year 2025 results that show lower net income while sales remained close to prior levels, and the company also declared a fully franked interim dividend.\nSee our latest analysis for Australian Clinical Labs.\nThe latest half year result and interim dividend have arrived against a weaker backdrop for shareholders, with the share price at A$2.15 after a 30 day share price return decline of 15.35% and a 1 year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/a-look-at-australian-clinical-labs-asxacl-valuation-after-so","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/a-look-at-australian-clinical-labs-asxacl-valuation-after-so","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","ACL.AU","XAO.AU","XJO.AU"],"gpt_icon":0},{"id":"2611179063","title":"Australian Clinical Labs Inflicts Pain With Profit Downgrade, CEO Exit -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2611179063","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611179063?lang=en_us&edition=fundamental","pubTime":"2026-02-16 07:39","pubTimestamp":1771198740,"startTime":"0","endTime":"0","summary":"2339 GMT - Australian Clinical Labs' strong cost control in 1H was overshadowed by an earnings downgrade and the departure of CEO Melinda McGrath, says Ord Minnett. Shares of ACL drop 9.5% to A$2.19 in early trading. ACL reported 1H underlying Ebit of A$28.0 million, up some 7% on Ord Minnett's estimate. Underlying net profit was a 9% beat to the bank's forecasts. Still, ACL expects FY 2026 Ebit of A$64 million-A$67 million, representing a 6% downgrade at the midpoint. \"Overall, a better-than-expected 1H26 result  but we expect the focus to be on the downgraded FY 2026 guidance, a weaker set-up for FY 2027 and the CEO exit,\" analyst Tom Godfrey says. \"ACL's share price has declined 9% over the last month into the result and we expect further weakness today.\" ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Australian Clinical Labs Inflicts Pain With Profit Downgrade, CEO Exit -- Market Talk","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACL.AU","BK7124"],"gpt_icon":0},{"id":"2611793051","title":"BRIEF-Australian Clinical Labs Group CEO Melinda Mcgrath Confirms Will Not Be Renewing Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2611793051","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611793051?lang=en_us&edition=fundamental","pubTime":"2026-02-16 06:46","pubTimestamp":1771195596,"startTime":"0","endTime":"0","summary":"BRIEF-Australian Clinical Labs Group CEO Melinda Mcgrath Confirms Will Not Be Renewing ContractFeb 16  - Australian Clinical Labs Ltd ACL.AX:GROUP CEO MELINDA MCGRATH CONFIRMED WILL NOT BE RENEWING CONTRACT FOLLOWING CONCLUSION ON 30 AUGUSTFurther company coverage: ACL.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260215:nFWN3ZB00R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","ACL.AU"],"gpt_icon":0},{"id":"2611767181","title":"Australian Clinical Labs Ltd -  Group CEO Melinda McGrath Confirmed Will Not Be Renewing Contract Following Conclusion on 30 August","url":"https://stock-news.laohu8.com/highlight/detail?id=2611767181","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611767181?lang=en_us&edition=fundamental","pubTime":"2026-02-16 06:23","pubTimestamp":1771194204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260215:nFWN3ZB00R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","ACL.AU"],"gpt_icon":0},{"id":"2611750141","title":"BRIEF-Australian Clinical Labs Sees FY26 Revenue A$735M - A$745M","url":"https://stock-news.laohu8.com/highlight/detail?id=2611750141","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611750141?lang=en_us&edition=fundamental","pubTime":"2026-02-16 05:15","pubTimestamp":1771190129,"startTime":"0","endTime":"0","summary":"BRIEF-Australian Clinical Labs Sees FY26 Revenue A$735M - A$745MFeb 16 (Reuters) - Australian Clinical Labs Ltd ACL.AX:SEES FY26 REVENUE A$735M - A$745MSEES FY26 UNDERLYING EBIT A$66M - A$69MFurther company coverage: ACL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260215:nFWN3Z91SU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACL.AU","BK7124"],"gpt_icon":0},{"id":"2608688740","title":"3 ASX Penny Stocks With Market Caps Under A$600M To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2608688740","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608688740?lang=en_us&edition=fundamental","pubTime":"2026-02-02 03:02","pubTimestamp":1769972552,"startTime":"0","endTime":"0","summary":"As the Australian market shows signs of recovery, with the ASX 200 futures indicating a potential uptick, investors are keeping a close eye on various opportunities. Penny stocks, often associated with smaller or newer companies, remain an intriguing area for those looking to diversify their portfolios beyond well-known names. Despite being considered somewhat outdated as a term, penny stocks continue to offer potential growth opportunities when backed by strong financial health.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/3-asx-penny-stocks-with-market-caps-under-a600m-to-consider-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-acl/australian-clinical-labs-shares/news/3-asx-penny-stocks-with-market-caps-under-a600m-to-consider-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7062","XKO.AU","EDU.AU","BK7095","SKS.AU","BK7104","SSM.AU","BK7016","BK7503","BK7506","XAO.AU","BK7055","BK7060","BK7023","BK7077","BK7124","VRS.AU","BK7132","IGL.AU","DSK.AU","BK7050","BK7143","BK7128","ACL.AU","MTO.AU","XJO.AU","WAF.AU","FHE.AU","MXI.AU","HSN.AU","AEF.AU","BK7045"],"gpt_icon":0},{"id":"2589865176","title":"The 2025 AGM Season Shows Shareholder Scrutiny, Focus on Board Accountability, Says Jarden","url":"https://stock-news.laohu8.com/highlight/detail?id=2589865176","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589865176?lang=en_us&edition=fundamental","pubTime":"2025-12-05 13:43","pubTimestamp":1764913425,"startTime":"0","endTime":"0","summary":"The 2025 annual general meeting season reflected elevated shareholder scrutiny, with investors remaining focused on board accountability, credible remuneration design, and governance track records, ac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NWH.AU","BK7511","BK4195","ACL.AU","BK7501","BK7132","REH.AU","BK7055","AGM","BK7135","BK7012","ANZ.AU","CSL.AU","BK7508","WBC.AU","BK7044","IEL.AU","JHX.AU","BK7031","BK7124","BK4229","NAB.AU","RWC.AU","BK7067"],"gpt_icon":0},{"id":"2588096773","title":"Optiscan Imaging, Australian Clinical Labs to Collaborate on Head, Neck Cancer Surgery Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096773","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588096773?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:02","pubTimestamp":1764730937,"startTime":"0","endTime":"0","summary":"Optiscan Imaging (ASX:OIL) will conduct an imaging study in head and neck cancer surgery in collaboration with Australian Clinical Labs (ASX:ACL) using Optiscan's InVue precision surgery and InForm di","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7124","OIL.AU","BK7007","XJO.AU","XKO.AU","ACL.AU"],"gpt_icon":0},{"id":"2586262069","title":"We’re not in Kansas anymore","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262069","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586262069?lang=en_us&edition=fundamental","pubTime":"2025-11-27 04:15","pubTimestamp":1764188107,"startTime":"0","endTime":"0","summary":"One only needs to glance at a map of the US equity market to determine ‘We’re not in Kansas anymore’. The era of network economics and ever greater financialisation has wrought massive change on equity markets and increasingly on the real economy.Ever-growing government deficits and strong ongoing growth in household borrowing are funding a relatively buoyant profit environment, albeit one that is distributed increasingly unevenly. Disequilibrium is becoming the norm and the economic forces which tended to work against this are proving ineffective. While the reasons for this ongoing disequilibrium are debatable, a few seem important.Keen to display the power of monetary intervention in ‘smoothing’ economic cycles and preventing any downturn, central bankers everywhere have ensured additional credit and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["HLS.AU","MQG.AU","BK7067","XKO.AU","BK7124","CSL.AU","BK7509","XJO.AU","BK7046","BK7511","XAO.AU","ACL.AU","SHL.AU","BK7508","MPL.AU","CBA.AU","BK7113","BK7089","BK7135","BK7501","RHC.AU"],"gpt_icon":0},{"id":"2585311385","title":"MOEA Takes Home 7 Awards at R&D100","url":"https://stock-news.laohu8.com/highlight/detail?id=2585311385","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585311385?lang=en_us&edition=fundamental","pubTime":"2025-11-21 16:30","pubTimestamp":1763713800,"startTime":"0","endTime":"0","summary":"18 Years, 100+ Awards: Taiwan's R&D Prowess Shines on Global StageTAIPEI, Nov. 21, 2025 /PRNewswire/ -- Taiwan's Ministry of Economic Affairs  announced today  that six technologies it funded have won seven awards at the 2025 R&D 100 Awards, often hailed as the \"Oscars of Innovation.\" The award-winning technologies include three from the Industrial Technology Research Institute , one from the Taiwan Textile Research Institute , one from the Metal Industries Research & Development Centre  , and one from the Institute for Information Industry . The winning technologies span key fields including AI, biomedical and healthcare, and green technology. Standing alongside world-renowned institutions, Taiwan's robust innovation and R&D capabilities are once again showcased on the international stage.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2829586/Taiwan_s_Ministry_of_Economic_Affairs__MOEA__announced_today__21st__that_six_technologies_it_funded.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2829586/Taiwan_s_Ministry_of_Economic_Affairs__MOEA__announced_today__21st__that_six_technologies_it_funded.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/moea-takes-home-7-awards-at-rd100-302622999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4588","III","ITRI","BK4134","BK4585","ACL.AU","IE00BGHQF417.EUR","LU2308191902.HKD","BK4587","BK4528","BK4195","AI","BK7124","BK4543","IE00B2PGVK34.USD","BK4211","BILS","CFA.SI","BK4023","HBCP","LU2048586759.USD","IE00B3CCJ633.GBP","BK4157"],"gpt_icon":0},{"id":"2584921383","title":"Optiscan Imaging Enters Strategic Collaboration With Australian Clinical Labs","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921383","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584921383?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:08","pubTimestamp":1763572088,"startTime":"0","endTime":"0","summary":"Nov 10 (Reuters) - Optiscan Imaging Ltd ::*STRATEGIC COLLABORATION WITH AUSTRALIAN CLINICAL LABS TO ACCELERATE DIGITAL PATHOLOGY INNOVATION AND DEPLOYMENT*Further company coverage: OIL.AX* ((Reuters.B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD5Jv9HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","BK7007","ACL.AU","OIL.AU"],"gpt_icon":0},{"id":"2577327171","title":"Australian Clinical Labs Ltd-Update - Notification of Buy-Back - Acl","url":"https://stock-news.laohu8.com/highlight/detail?id=2577327171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577327171?lang=en_us&edition=fundamental","pubTime":"2025-10-23 14:35","pubTimestamp":1761201331,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUEKVTF5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACL.AU","BK7124"],"gpt_icon":0},{"id":"2577345652","title":"BUZZ-Australian Clinical Labs hits seven-week high on share buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2577345652","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577345652?lang=en_us&edition=fundamental","pubTime":"2025-10-23 07:59","pubTimestamp":1761177560,"startTime":"0","endTime":"0","summary":"BUZZ-Australian Clinical Labs hitsseven-week high on share buyback** Shares of Australian Clinical Labs ACL.AX rise as much as 5.1% to A$2.66, marking their highest level since September 4** Pathology","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nL6N3W313X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","ACL.AU"],"gpt_icon":0},{"id":"2577312654","title":"Australian Clinical Labs Ltd - on Market Share Buy Back of up to 19.5 Mln Acl Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2577312654","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577312654?lang=en_us&edition=fundamental","pubTime":"2025-10-23 05:20","pubTimestamp":1761168056,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nFWN3W337N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACL.AU","BK7124"],"gpt_icon":0},{"id":"2577580012","title":"Australian Clinical Labs Ltd-Resignation of DR Leanne Rowe Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2577580012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577580012?lang=en_us&edition=fundamental","pubTime":"2025-10-22 05:25","pubTimestamp":1761081918,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nTUEFX5HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","ACL.AU"],"gpt_icon":0},{"id":"2573447819","title":"BRIEF-Australian Clinical Labs Says Court Approves Agreement With Australian Information Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2573447819","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573447819?lang=en_us&edition=fundamental","pubTime":"2025-10-08 18:18","pubTimestamp":1759918724,"startTime":"0","endTime":"0","summary":"BRIEF-Australian Clinical Labs Says Court Approves Agreement With Australian Information CommissionerOct 8  - Australian Clinical Labs Ltd ACL.AX:COURT APPROVES AGREEMENT WITH AUSTRALIAN INFORMATION COMMISSIONERCO WILL PAY AGGREGATE CIVIL PENALTIES OF A$5.8 MILLIONFurther company coverage: ACL.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VO2SS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACL.AU","BK7124"],"gpt_icon":0},{"id":"2573255911","title":"Australian Clinical Labs Ltd - Co Will Pay Aggregate Civil Penalties of a$5.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2573255911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573255911?lang=en_us&edition=fundamental","pubTime":"2025-10-08 12:49","pubTimestamp":1759898979,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VO2SS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","ACL.AU"],"gpt_icon":0},{"id":"2571808109","title":"BUZZ-Australian Clinical Labs falls on $3.8 million penalty","url":"https://stock-news.laohu8.com/highlight/detail?id=2571808109","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571808109?lang=en_us&edition=fundamental","pubTime":"2025-09-29 12:36","pubTimestamp":1759120614,"startTime":"0","endTime":"0","summary":"BUZZ-Australian Clinical Labs falls on $3.8 million penalty ** Shares of Australian Clinical Labs ACL.AX fall as much as 1.2% to A$2.46, posting their biggest intraday pct loss since September 22** Pathology services provider says it has reached an agreement with the Australian Information Commissioner to resolve civil penalty proceedings** Says proceedings commenced in the Federal Court of Australia in November 2023 relating to a February 2022 cyberattack on Medlab Pathology** Says agreement proposes co to pay penalty of A$5.8 million , and make contribution of A$400,000 towards commissioner's legal costs** Says cyberattack occurred about nine weeks after co's acquisition of Medlab business** Stock down 28.3% YTD, including the day's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nL6N3VG07V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACL.AU","BK7124"],"gpt_icon":0},{"id":"2571874135","title":"Australian Clinical Labs Ltd - Proposes a$5.8 Mln Penalty","url":"https://stock-news.laohu8.com/highlight/detail?id=2571874135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571874135?lang=en_us&edition=fundamental","pubTime":"2025-09-29 10:22","pubTimestamp":1759112565,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VE0PH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","ACL.AU"],"gpt_icon":0},{"id":"2571874133","title":"Australian Clinical Labs Ltd - Acl and Australian Information Commissioner Reach Agreement on Privacy Act Proceeding","url":"https://stock-news.laohu8.com/highlight/detail?id=2571874133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571874133?lang=en_us&edition=fundamental","pubTime":"2025-09-29 10:22","pubTimestamp":1759112565,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VE0PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACL.AU","BK7124"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}